A detailed history of Squarepoint Ops LLC transactions in Xencor Inc stock. As of the latest transaction made, Squarepoint Ops LLC holds 24,495 shares of XNCR stock, worth $506,311. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,495
Previous 17,230 42.16%
Holding current value
$506,311
Previous $326,000 50.92%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.7 - $21.65 $114,060 - $157,287
7,265 Added 42.16%
24,495 $492,000
Q2 2024

Aug 14, 2024

BUY
$18.21 - $24.5 $313,758 - $422,135
17,230 New
17,230 $326,000
Q2 2023

Aug 14, 2023

BUY
$24.77 - $29.9 $732,894 - $884,681
29,588 New
29,588 $738,000
Q4 2022

Feb 14, 2023

SELL
$24.79 - $30.86 $479,512 - $596,924
-19,343 Reduced 58.51%
13,714 $357,000
Q3 2022

Nov 14, 2022

SELL
$24.62 - $32.44 $1.05 Million - $1.38 Million
-42,497 Reduced 56.25%
33,057 $859,000
Q2 2022

Aug 15, 2022

BUY
$19.74 - $29.01 $282,400 - $415,017
14,306 Added 23.36%
75,554 $2.07 Million
Q1 2022

May 16, 2022

BUY
$26.68 - $41.63 $1.63 Million - $2.55 Million
61,248 New
61,248 $1.63 Million
Q3 2021

Nov 15, 2021

SELL
$30.65 - $35.68 $1.69 Million - $1.96 Million
-55,063 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$34.33 - $44.68 $4.11 Million - $5.35 Million
-119,681 Reduced 68.49%
55,063 $1.9 Million
Q1 2021

May 17, 2021

BUY
$40.81 - $53.88 $6.55 Million - $8.65 Million
160,542 Added 1130.42%
174,744 $7.52 Million
Q4 2020

Feb 16, 2021

BUY
$36.63 - $47.63 $274,798 - $357,320
7,502 Added 111.97%
14,202 $620,000
Q3 2020

Nov 16, 2020

SELL
$30.09 - $43.02 $1.37 Million - $1.95 Million
-45,430 Reduced 87.15%
6,700 $260,000
Q2 2020

Aug 14, 2020

BUY
$27.76 - $33.42 $847,790 - $1.02 Million
30,540 Added 141.45%
52,130 $1.69 Million
Q1 2020

May 15, 2020

BUY
$20.69 - $37.79 $5,855 - $10,694
283 Added 1.33%
21,590 $645,000
Q4 2019

Feb 14, 2020

SELL
$32.75 - $41.43 $482,145 - $609,932
-14,722 Reduced 40.86%
21,307 $733,000
Q3 2019

Nov 14, 2019

SELL
$33.73 - $46.27 $675,274 - $926,325
-20,020 Reduced 35.72%
36,029 $1.22 Million
Q2 2019

Aug 14, 2019

BUY
$29.6 - $40.93 $452,613 - $625,860
15,291 Added 37.52%
56,049 $2.29 Million
Q1 2019

May 15, 2019

BUY
$27.85 - $38.09 $864,881 - $1.18 Million
31,055 Added 320.06%
40,758 $1.27 Million
Q4 2018

Feb 14, 2019

SELL
$32.39 - $42.05 $375,626 - $487,653
-11,597 Reduced 54.45%
9,703 $351,000
Q3 2018

Nov 14, 2018

BUY
$35.69 - $47.65 $389,021 - $519,385
10,900 Added 104.81%
21,300 $830,000
Q2 2018

Aug 14, 2018

SELL
$28.41 - $42.41 $72,360 - $108,018
-2,547 Reduced 19.67%
10,400 $385,000
Q1 2018

May 15, 2018

SELL
$21.18 - $33.78 $210,105 - $335,097
-9,920 Reduced 43.38%
12,947 $388,000
Q4 2017

Feb 14, 2018

BUY
$19.29 - $24.83 $441,104 - $567,787
22,867
22,867 $501,000

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.23B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.